重庆啤酒股份有限公司2023年第三季度报告(英文版)

Q3 Report of 2023 1 / 18 Stock Code: 600132 Stock Abbreviation: Chongqing Brewery Chongqing Brewery Co., Ltd. Q3 Report of 2023 The board of directors and all directors of the company guarantee that this announcement is free of any false records, misleading statements or significant omissions, and that they will bear legal responsibility for the authenticity, accuracy and completeness of its content. Reminder of important content: The board of directors, board of supervisors, directors, supervisors and senior management of the company guarantee that this quarterly report contains true, accurate and complete information and is free of any false records, misleading statements or significant omissions, and that they will be jointly and severally liable for the legal consequences. The legal representative of the company, officer in charge of accounting and head of accounting department (the chief accountant) guarantee that the financial information in the quarterly report is true, accurate and complete. Whether the Q3 financial statements are audited □Yes √No Q3 Report of 2023 2 / 18 I. Key financial information (I) Major accounting data and financial indicators Unit: yuan Currency: RMB Item For the quarter ended September 30, 2023 (“the reporting period”) For the quarter ended September 30, 2022 Rate of change (%) For the three quarters ended September 30, 2023 For the three quarters ended September 30, 2022 Rate of change (%) Before retrospective adjustment After retrospective adjustment After retrospective adjustment Before retrospective adjustment After retrospective adjustment After retrospective adjustment Operating revenue 4,523,879,342.82 4,247,364,892.75 4,247,364,892.75 6.51% 13,028,681,199.38 12,183,116,035.30 12,183,116,035.30 6.94% Net profit attributable to shareholders of the Company 479,080,499.95 454,728,429.61 454,867,771.85 5.32% 1,344,089,296.32 1,182,303,204.39 1,182,418,780.75 13.67% Net profit attributable to shareholders of the Company excluding non-recurring gains and losses 472,823,195.86 445,285,432.32 445,424,774.56 6.15% 1,326,981,171.32 1,161,030,910.61 1,161,146,486.97 14.28% Net cash flows from operating activities —— —— —— —— 3,718,311,643.18 4,202,540,081.28 4,202,540,081.28 -11.52% Basic earnings per share 0.99 0.94 0.94 5.32% 2.78 2.44 2.44 13.67% Q3 Report of 2023 3 / 18 Diluted earnings per share 0.99 0.94 0.94 5.32% 2.78 2.44 2.44 13.67% Weighted average ROE (%) 25.27 26.08 26.09 Decreased by0.82 p.p. 61.99 61.67 61.68 Increased by 0.31 p.p. As of September 30, 2023 As of December 31, 2022 Rate of change (%) Before retrospective adjustment After retrospective adjustment After retrospective adjustment Total assets 14,049,739,569.56 12,497,542,168.83 12,497,582,459.14 12.42% Net assets attributable to shareholders of the Company 2,140,727,533.54 2,056,155,782.63 2,056,176,499.91 4.11% Note: "The reporting period" refers to the quarter end

立即下载
综合
2023-10-31
18页
0.29M
收藏
分享

重庆啤酒股份有限公司2023年第三季度报告(英文版),点击即可下载。报告格式为PDF,大小0.29M,页数18页,欢迎下载。

本报告共18页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共18页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
65家中药板块上市公司2023Q3销售费用率环比增减排序:%
综合
2023-11-13
来源:中药Ⅱ行业跟踪报告:Q3业绩承压,销售费用同比环比均下降
查看原文
65家中药板块上市公司2023Q3销售费用率同比增减排序:%
综合
2023-11-13
来源:中药Ⅱ行业跟踪报告:Q3业绩承压,销售费用同比环比均下降
查看原文
65家中药板块上市公司2023Q3销售费用率排序:%
综合
2023-11-13
来源:中药Ⅱ行业跟踪报告:Q3业绩承压,销售费用同比环比均下降
查看原文
中药板块销售费用率 图表17:中药板块销售费用率(按季度)
综合
2023-11-13
来源:中药Ⅱ行业跟踪报告:Q3业绩承压,销售费用同比环比均下降
查看原文
65家中药板块上市公司2023Q3销售费用环比增长排序:亿元
综合
2023-11-13
来源:中药Ⅱ行业跟踪报告:Q3业绩承压,销售费用同比环比均下降
查看原文
65家中药板块上市公司2023Q3销售费用同比增长排序:亿元
综合
2023-11-13
来源:中药Ⅱ行业跟踪报告:Q3业绩承压,销售费用同比环比均下降
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起